

House
Study
Bill
653
-
Introduced


HOUSE
FILE
_____


BY
(PROPOSED
COMMITTEE
ON


PUBLIC
SAFETY
BILL
BY


CHAIRPERSON
KLEIN)


A
BILL
FOR


An
Act
concerning
the
medical
cannabidiol
Act.
1


BE
IT
ENACTED
BY
THE
GENERAL
ASSEMBLY
OF
THE
STATE
OF
IOWA:
2


TLSB
5589YC
(6)
88


ss/rh



H.F.
_____


DIVISION
I
1


MEDICAL
CANNABIDIOL
PROGRAM
2


Section
1.
Section
124E.1,
Code
2020,
is
amended
to
read
as
3


follows:
4


124E.1
Short
title.
5


This
chapter
shall
be
known
and
may
be
cited
as
the
“Medical
6


Cannabidiol


Cannabis
Act”
.
7


Sec.
2.
Section
124E.2,
subsections
5
and
6,
Code
2020,
are
8


amended
to
read
as
follows:
9


5.
“Health
care
practitioner”
means
an
individual
licensed
10


under
chapter
148
to
practice
medicine
and
surgery
or
11


osteopathic
medicine
and
surgery
,
a
physician
assistant


12


licensed
under
chapter
148C,
a
podiatrist
licensed
pursuant
to
13


chapter
149,
an
advanced
registered
nurse
practitioner
licensed


14


under
chapter
152,
or
an
advanced
practice
registered
nurse
15


under
chapter
152E,
who
is
a
patient’s
primary
care
provider.
16


“Health
care
practitioner”
shall
not
include
a
physician
17


assistant
licensed
under


chapter
148C
or
an
advanced
registered
18


nurse
practitioner
licensed
pursuant
to


chapter
152
or
152E
.
19


6.
“Medical
cannabidiol”
cannabis”
means
any
pharmaceutical
20


grade
cannabinoid
found
in
the
plant
Cannabis
sativa
L.
or
21


Cannabis
indica
or
any
other
preparation
thereof
that
has


22


a
tetrahydrocannabinol
level
of
no
more
than
three
percent


23


and
that
is
delivered
in
a
form
recommended
by
the
medical
24


cannabidiol
cannabis
board,
approved
by
the
board
of
medicine,
25


and
adopted
by
the
department
pursuant
to
rule.
26


Sec.
3.
Section
124E.2,
Code
2020,
is
amended
by
adding
the
27


following
new
subsection:
28


NEW
SUBSECTION
.
7A.
“Total
tetrahydrocannabinol”
means
29


the
amount
of
tetrahydrocannabinol
plus
the
amount
of
30


tetrahydrocannabinolic
acid.
31


Sec.
4.
Section
124E.4,
subsection
1,
unnumbered
paragraph
32


1,
Code
2020,
is
amended
to
read
as
follows:
33


Subject
to
subsection
7
,
the
department
may
approve
the


34


issuance
of
issue
a
medical
cannabidiol
cannabis
registration
35


-1-


LSB
5589YC
(6)
88


ss/rh
1/
25

































H.F.
_____


card
by
the
department
of
transportation
to
a
patient
who:
1


Sec.
5.
Section
124E.4,
subsection
1,
paragraph
d,
2


unnumbered
paragraph
1,
Code
2020,
is
amended
to
read
as
3


follows:
4


Submits
an
application
to
the
department,
on
a
form
created
5


by
the
department,
in
consultation
with
the
department
of


6


transportation,
that
contains
all
of
the
following:
7


Sec.
6.
Section
124E.4,
subsection
1,
paragraph
f,
Code
8


2020,
is
amended
by
striking
the
paragraph.
9


Sec.
7.
Section
124E.4,
subsection
2,
unnumbered
paragraph
10


1,
Code
2020,
is
amended
to
read
as
follows:
11


A
medical
cannabidiol


cannabis
registration
card
issued
12


to
a
patient
by
the
department
of
transportation
pursuant
to
13


subsection
1
shall
contain,
at
a
minimum,
all
of
the
following:
14


Sec.
8.
Section
124E.4,
subsection
3,
unnumbered
paragraph
15


1,
Code
2020,
is
amended
to
read
as
follows:
16


For
a
patient
in
a
primary
caregiver’s
care,
subject
to
17


subsection
7
,
the
department
may
approve
the
issuance
of


18


issue


a
medical
cannabidiol
cannabis
registration
card
by
the
19


department
of
transportation
to
the
primary
caregiver
who:
20


Sec.
9.
Section
124E.4,
subsection
3,
paragraph
b,
21


unnumbered
paragraph
1,
Code
2020,
is
amended
to
read
as
22


follows:
23


Submits
an
application
to
the
department,
on
a
form
created
24


by
the
department,
in
consultation
with
the
department
of


25


transportation,
that
contains
all
of
the
following:
26


Sec.
10.
Section
124E.4,
subsection
3,
paragraph
c,
Code
27


2020,
is
amended
by
striking
the
paragraph.
28


Sec.
11.
Section
124E.4,
subsection
4,
unnumbered
paragraph
29


1,
Code
2020,
is
amended
to
read
as
follows:


30


A
medical
cannabidiol


cannabis
registration
card
issued
31


by
the
department
of
transportation


to
a
primary
caregiver
32


pursuant
to
subsection
3
shall
contain,
at
a
minimum,
all
of
33


the
following:
34


Sec.
12.
Section
124E.4,
subsection
6,
Code
2020,
is
amended


35


-2-


LSB
5589YC
(6)
88


ss/rh
2/
25




















H.F.
_____


by
striking
the
subsection.
1


Sec.
13.
Section
124E.5,
subsection
2,
Code
2020,
is
amended
2


to
read
as
follows:
3


2.
The
medical
cannabidiol


cannabis
board
shall
convene
at
4


least
twice
but
no
more
than
four
times


per
year.
5


Sec.
14.
Section
124E.5,
subsection
6,
Code
2020,
is
amended
6


to
read
as
follows:
7


6.
The
medical
cannabidiol
board
may
recommend
a
statutory


8


revision
to
the
definition
of
medical
cannabidiol
contained
in


9


this
chapter
that
increases
the
tetrahydrocannabinol
level
to
10


more
than
three
percent,
however,
any
such
recommendation
shall


11


be
submitted
to
the
general
assembly
during
the
regular
session
12


of
the
general
assembly
following
such
submission.
The
general
13


assembly
shall
have
the
sole
authority
to
revise
the
definition
14


of
medical
cannabidiol


cannabis
for
purposes
of
this
chapter
.
15


Sec.
15.
Section
124E.9,
Code
2020,
is
amended
by
adding
the
16


following
new
subsections:
17


NEW
SUBSECTION


.
13.
A
medical
cannabis
dispensary
shall
18


employ
a
pharmacist
or
pharmacy
technician
licensed
or
19


registered
pursuant
to
chapter
155A
for
the
purpose
of
making
20


dosing
recommendations.
21


NEW
SUBSECTION


.
14.
A
medical
cannabis
dispensary
shall
not
22


dispense
more
than
a
combined
total
of
four
and
one-half
grams
23


of
total
tetrahydrocannabinol
to
a
patient
and
the
patient’s
24


primary
caregiver
in
a
ninety-day
period.
The
department
may
25


decrease
this
limit
by
rule
as
provided
in
section
124E.11,
26


subsection
2,
paragraph
“c”
.
27


Sec.
16.
Section
124E.11,
subsection
1,
paragraph
b,
28


subparagraph
(1),
subparagraph
division
(a),
Code
2020,
is
29


amended
to
read
as
follows:
30


(a)
To
authorized
employees
or
agents
of
the
department
and


31


the
department
of
transportation


as
necessary
to
perform
the
32


duties
of
the
department
and
the
department
of
transportation
33


pursuant
to
this
chapter
.
34


Sec.
17.
Section
124E.11,
subsection
1,
paragraph
b,
35


-3-


LSB
5589YC
(6)
88


ss/rh
3/
25




















H.F.
_____


subparagraph
(1),
subparagraph
division
(c),
Code
2020,
is
1


amended
to
read
as
follows:
2


(c)
To
authorized
employees
of
a
medical
cannabidiol


3


cannabis
dispensary,
but
only
for
the
purpose
purposes
4


of
verifying
that
a
person
is
lawfully
in
possession
of
a
5


medical
cannabidiol
cannabis
registration
card
issued
pursuant
6


to
this
chapter
and
that
a
person
has
not
purchased
total
7


tetrahydrocannabinol
in
excess
of
the
amount
authorized
by
this
8


chapter


.
9


Sec.
18.
Section
124E.11,
subsection
1,
paragraph
b,
10


subparagraph
(1),
Code
2020,
is
amended
by
adding
the
following
11


new
subparagraph
division:
12


NEW
SUBPARAGRAPH
DIVISION


.
(e)
To
a
health
care
13


practitioner
for
the
purpose
of
determining
whether
a
patient
14


seeking
a
written
certification
pursuant
to
section
124E.3
has
15


already
received
a
written
certification
from
another
health
16


care
practitioner.
17


Sec.
19.
Section
124E.12,
subsection
7,
Code
2020,
is
18


amended
to
read
as
follows:
19


7.
Notwithstanding
any
law
to
the
contrary,
the
department,
20


the
department
of
transportation,


the
governor,
or
any
employee
21


of
any
state
agency
shall
not
be
held
civilly
or
criminally
22


liable
for
any
injury,
loss
of
property,
personal
injury,
or
23


death
caused
by
any
act
or
omission
while
acting
within
the
24


scope
of
office
or
employment
as
authorized
under
this
chapter
.
25


Sec.
20.
NEW
SECTION


.
124E.20
Observational
effectiveness
26


study.
27


The
department
may
conduct
an
observational
effectiveness
28


study
in
cooperation
with
patients
and
health
care
29


practitioners
and
pursuant
to
rules
of
the
department
in
order
30


to
study
the
effectiveness
of
medical
cannabis
in
the
treatment
31


of
debilitating
medical
conditions.
32


Sec.
21.
PROTECTION
OF
FEDERAL
FUNDING.
The
department
33


of
public
health
shall
request
guarantees
from
the
agencies
34


of
the
federal
government
providing
funding
to
educational
35


-4-


LSB
5589YC
(6)
88


ss/rh
4/
25















H.F.
_____


and
long-term
care
facilities
that
facilities
with
policies
1


allowing
patients
to
possess
medical
cannabis
on
the
grounds
2


of
the
facilities
consistent
with
chapter
124E
or
allowing
3


facility
staff
to
administer
medical
cannabis
to
a
patient
4


shall
not
lose
eligibility
for
any
federal
funding
due
to
such
5


policies.
6


Sec.
22.
TRANSITION
PROVISIONS.
A
medical
cannabidiol
7


registration
card
issued
prior
to
July
1,
2020,
remains
8


effective
and
continues
in
effect
as
issued
for
the
9


twelve-month
period
following
its
issuance.
10


DIVISION
II
11


MEDICAL
CANNABIDIOL
PROGRAM
NAME
CHANGE
——
CONFORMING
CODE
12


CHANGES
13


Sec.
23.
Section
124.401,
subsection
5,
unnumbered
14


paragraph
3,
Code
2020,
is
amended
to
read
as
follows:
15


A
person
may
knowingly
or
intentionally
recommend,
possess,
16


use,
dispense,
deliver,
transport,
or
administer
cannabidiol


17


medical
cannabis


if
the
recommendation,
possession,
use,
18


dispensing,
delivery,
transporting,
or
administering
is
in
19


accordance
with
the
provisions
of
chapter
124E
.
For
purposes
20


of
this
paragraph,
“cannabidiol”


“medical
cannabis”
means
the
21


same
as
defined
in
section
124E.2
.
22


Sec.
24.
Section
124E.2,
subsection
7,
Code
2020,
is
amended
23


to
read
as
follows:
24


7.
“Primary
caregiver”
means
a
person
who
is
a
resident
of
25


this
state
or
a
bordering
state
as
defined
in
section
331.910
,
26


including
but
not
limited
to
a
parent
or
legal
guardian,
at
27


least
eighteen
years
of
age,
who
has
been
designated
by
a
28


patient’s
health
care
practitioner
as
a
necessary
caretaker
29


taking
responsibility
for
managing
the
well-being
of
the
30


patient
with
respect
to
the
use
of
medical
cannabidiol


cannabis
31


pursuant
to
the
provisions
of
this
chapter
.
32


Sec.
25.
Section
124E.3,
subsection
1,
Code
2020,
is
amended
33


to
read
as
follows:
34


1.
Prior
to
a
patient’s
submission
of
an
application
for
35


-5-


LSB
5589YC
(6)
88


ss/rh
5/
25









H.F.
_____


a
medical
cannabidiol
cannabis
registration
card
pursuant
to
1


section
124E.4
,
a
health
care
practitioner
shall
do
all
of
the
2


following:
3


a.
Determine,
in
the
health
care
practitioner’s
medical
4


judgment,
whether
the
patient
whom
the
health
care
practitioner
5


has
examined
and
treated
suffers
from
a
debilitating
medical
6


condition
that
qualifies
for
the
use
of
medical
cannabidiol


7


cannabis
under
this
chapter
,
and
if
so
determined,
provide
the
8


patient
with
a
written
certification
of
that
diagnosis.
9


b.
Provide
explanatory
information
as
provided
by
the
10


department
to
the
patient
about
the
therapeutic
use
of
medical
11


cannabidiol


cannabis
and
the
possible
risks,
benefits,
and
side
12


effects
of
the
proposed
treatment.
13


Sec.
26.
Section
124E.4,
subsection
1,
paragraph
e,
Code
14


2020,
is
amended
to
read
as
follows:
15


e.
Submits
a
medical
cannabidiol


cannabis
registration
card
16


fee
of
one
hundred
dollars
to
the
department.
If
the
patient
17


attests
to
receiving
social
security
disability
benefits,
18


supplemental
security
insurance
payments,
or
being
enrolled
in
19


the
medical
assistance
program,
the
fee
shall
be
twenty-five
20


dollars.
21


Sec.
27.
Section
124E.4,
subsection
2,
paragraph
c,
Code
22


2020,
is
amended
to
read
as
follows:
23


c.
The
date
of
issuance
and
expiration
date
of
the
medical
24


cannabidiol


cannabis
registration
card.
25


Sec.
28.
Section
124E.4,
subsection
3,
paragraph
d,
Code
26


2020,
is
amended
to
read
as
follows:


27


d.
Submits
a
medical
cannabidiol


cannabis
registration
card
28


fee
of
twenty-five
dollars
to
the
department.
29


Sec.
29.
Section
124E.4,
subsection
4,
paragraph
d,
Code
30


2020,
is
amended
to
read
as
follows:


31


d.
The
medical
cannabidiol


cannabis
registration
card
32


number
of
each
patient
in
the
primary
caregiver’s
care.
If
33


the
patient
in
the
primary
caregiver’s
care
is
under
the
age
34


of
eighteen,
the
full
name
of
the
patient’s
parent
or
legal
35


-6-


LSB
5589YC
(6)
88


ss/rh
6/
25

















H.F.
_____


guardian.
1


Sec.
30.
Section
124E.4,
subsections
5
and
7,
Code
2020,
are
2


amended
to
read
as
follows:
3


5.
Expiration
date
of
card.
A
medical
cannabidiol


cannabis
4


registration
card
issued
pursuant
to
this
section
shall
expire
5


one
year
after
the
date
of
issuance
and
may
be
renewed.
6


7.
Federally
approved
clinical
trials.
The
department
shall
7


not
approve
the
issuance
of
a
medical
cannabidiol
cannabis
8


registration
card
pursuant
to
this
section
for
a
patient
who
9


is
enrolled
in
a
federally
approved
clinical
trial
for
the
10


treatment
of
a
debilitating
medical
condition
with
medical
11


cannabidiol


cannabis
.
12


Sec.
31.
Section
124E.5,
subsection
1,
paragraphs
a
and
b,
13


Code
2020,
are
amended
to
read
as
follows:
14


a.
A
medical
cannabidiol


cannabis
board
is
created
15


consisting
of
eight
practitioners
representing
the
fields
16


of
neurology,
pain
management,
gastroenterology,
oncology,
17


psychiatry,
pediatrics,
family
medicine,
and
pharmacy,
and
one
18


representative
from
law
enforcement.
19


b.
The
practitioners
shall
be
licensed
in
this
state
and
20


nationally
board-certified
in
their
area
of
specialty
and
21


knowledgeable
about
the
use
of
medical
cannabidiol


cannabis
.
22


Sec.
32.
Section
124E.5,
subsections
3,
4,
and
5,
Code
2020,
23


are
amended
to
read
as
follows:
24


3.
The
duties
of
the
medical
cannabidiol


cannabis
board
25


shall
include
but
not
be
limited
to
the
following:
26


a.
Accepting
and
reviewing
petitions
to
add
medical
27


conditions,
medical
treatments,
or
debilitating
diseases
to
the
28


list
of
debilitating
medical
conditions
for
which
the
medical
29


use
of
cannabidiol


cannabis
would
be
medically
beneficial
under
30


this
chapter
.
31


b.
Making
recommendations
relating
to
the
removal
or
32


addition
of
debilitating
medical
conditions
to
the
list
33


of
allowable
debilitating
medical
conditions
for
which
the
34


medical
use
of
cannabidiol


cannabis
under
this
chapter
would
35


-7-


LSB
5589YC
(6)
88


ss/rh
7/
25



















H.F.
_____


be
medically
beneficial.
1


c.
Working
with
the
department
regarding
the
requirements
2


for
the
licensure
of
medical
cannabidiol


cannabis
manufacturers
3


and
medical
cannabidiol
cannabis
dispensaries,
including
4


licensure
procedures.
5


d.
Advising
the
department
regarding
the
location
of
medical
6


cannabidiol
cannabis
manufacturers
and
medical
cannabidiol
7


cannabis
dispensaries
throughout
the
state.
8


e.
Making
recommendations
relating
to
the
form
and
quantity
9


of
allowable
medical
uses
of
cannabidiol


cannabis
.
10


4.
Recommendations
made
by
the
medical
cannabidiol


cannabis
11


board
pursuant
to
subsection
3
,
paragraphs
“b”
and
“e”
,
shall
12


be
made
to
the
board
of
medicine
for
consideration,
and
if
13


approved,
shall
be
adopted
by
the
board
of
medicine
by
rule.
14


5.
On
or
before
January
1
of
each
year,
beginning
January
15


1,
2018,
the
medical
cannabidiol


cannabis
board
shall
submit
a
16


report
detailing
the
activities
of
the
board.
17


Sec.
33.
Section
124E.6,
Code
2020,
is
amended
to
read
as
18


follows:
19


124E.6
Medical
cannabidiol


cannabis
manufacturer
licensure.
20


1.
a.
The
department
shall
issue
a
request
for
proposals
21


to
select
and
license
by
December
1,
2017,
up
to
two
medical
22


cannabidiol


cannabis
manufacturers
to
manufacture
and
to
23


possess,
cultivate,
harvest,
transport,
package,
process,
24


or
supply
medical
cannabidiol
cannabis
within
this
state
25


consistent
with
the
provisions
of
this
chapter
.
The
department
26


shall
license
new
medical
cannabidiol
cannabis
manufacturers


27


or
relicense
the
existing
medical
cannabidiol


cannabis
28


manufacturers
by
December
1
of
each
year.
29


b.
Information
submitted
during
the
application
process
30


shall
be
confidential
until
a
medical
cannabidiol


cannabis
31


manufacturer
is
licensed
by
the
department
unless
otherwise
32


protected
from
disclosure
under
state
or
federal
law.
33


2.
As
a
condition
for
licensure,
a
medical
cannabidiol


34


cannabis
manufacturer
must
agree
to
begin
supplying
medical
35


-8-


LSB
5589YC
(6)
88


ss/rh
8/
25































H.F.
_____


cannabidiol
cannabis
to
medical
cannabidiol
cannabis
1


dispensaries
in
this
state
no
later
than
December
1,
2018.
2


3.
The
department
shall
consider
the
following
factors
in
3


determining
whether
to
select
and
license
a
medical
cannabidiol


4


cannabis


manufacturer:
5


a.
The
technical
expertise
of
the
medical
cannabidiol


6


cannabis
manufacturer
regarding
medical
cannabidiol
cannabis
.
7


b.
The
qualifications
of
the
medical
cannabidiol
cannabis
8


manufacturer’s
employees.
9


c.
The
long-term
financial
stability
of
the
medical
10


cannabidiol


cannabis
manufacturer.
11


d.
The
ability
to
provide
appropriate
security
measures
on
12


the
premises
of
the
medical
cannabidiol
cannabis
manufacturer.
13


e.
Whether
the
medical
cannabidiol


cannabis
manufacturer
14


has
demonstrated
an
ability
to
meet
certain
medical
cannabidiol
15


cannabis
production
needs
for
medical
use
regarding
the
range
16


of
recommended
dosages
for
each
debilitating
medical
condition,
17


the
range
of
chemical
compositions
of
any
plant
of
the
genus
18


cannabis
that
will
likely
be
medically
beneficial
for
each
19


of
the
debilitating
medical
conditions,
and
the
form
of
the
20


medical
cannabidiol


cannabis
in
the
manner
determined
by
the
21


department
pursuant
to
rule.
22


f.
The
medical
cannabidiol


cannabis
manufacturer’s
23


projection
of
and
ongoing
assessment
of
fees
on
patients
with
24


debilitating
medical
conditions.
25


4.
The
department
shall
require
each
medical
cannabidiol
26


cannabis
manufacturer
to
contract
with
the
state
hygienic
27


laboratory
at
the
university
of
Iowa
in
Iowa
City
or
an
28


independent
medical
cannabidiol
cannabis
testing
laboratory
to
29


perform
spot-check
testing
of
the
medical
cannabidiol


cannabis
30


produced
by
the
manufacturer
as
provided
in
section
124E.7
.
31


The
department
shall
require
that
the
laboratory
report
testing
32


results
to
the
manufacturer
in
a
manner
determined
by
the
33


department
pursuant
to
rule.
34


5.
Each
entity
submitting
an
application
for
licensure
35


-9-


LSB
5589YC
(6)
88


ss/rh
9/
25

































H.F.
_____


as
a
medical
cannabidiol
cannabis
manufacturer
shall
pay
a
1


nonrefundable
application
fee
of
seven
thousand
five
hundred
2


dollars
to
the
department.
3


Sec.
34.
Section
124E.7,
Code
2020,
is
amended
to
read
as
4


follows:
5


124E.7
Medical
cannabidiol


cannabis
manufacturers.
6


1.
A
medical
cannabidiol
cannabis
manufacturer
shall
7


contract
with
the
state
hygienic
laboratory
at
the
university
8


of
Iowa
in
Iowa
City
or
an
independent
medical
cannabidiol


9


cannabis
testing
laboratory
to
perform
spot-check
testing
of
10


the
medical
cannabidiol


cannabis
manufactured
by
the
medical
11


cannabidiol
cannabis
manufacturer
as
to
content,
contamination,
12


and
consistency.
The
cost
of
all
laboratory
testing
shall
be
13


paid
by
the
medical
cannabidiol


cannabis
manufacturer.
14


2.
The
operating
documents
of
a
medical
cannabidiol
15


cannabis
manufacturer
shall
include
all
of
the
following:
16


a.
Procedures
for
the
oversight
of
the
medical
cannabidiol
17


cannabis


manufacturer
and
procedures
to
ensure
accurate
18


recordkeeping.
19


b.
Procedures
for
the
implementation
of
appropriate
security
20


measures
to
deter
and
prevent
the
theft
of
medical
cannabidiol


21


cannabis
and
unauthorized
entrance
into
areas
containing
22


medical
cannabidiol


cannabis
.
23


3.
A
medical
cannabidiol
cannabis
manufacturer
shall
24


implement
security
requirements,
including
requirements
for
25


protection
of
each
location
by
a
fully
operational
security
26


alarm
system,
facility
access
controls,
perimeter
intrusion
27


detection
systems,
and
a
personnel
identification
system.
28


4.
A
medical
cannabidiol
cannabis
manufacturer
shall
29


not
share
office
space
with,
refer
patients
to,
or
have
any
30


financial
relationship
with
a
health
care
practitioner.
31


5.
A
medical
cannabidiol


cannabis
manufacturer
shall
not


32


permit
any
person
to
consume
medical
cannabidiol


cannabis
on
33


the
property
of
the
medical
cannabidiol


cannabis
manufacturer.
34


6.
A
medical
cannabidiol
cannabis
manufacturer
is
subject
35


-10-


LSB
5589YC
(6)
88


ss/rh
10/
25





































H.F.
_____


to
reasonable
inspection
by
the
department.
1


7.
A
medical
cannabidiol


cannabis
manufacturer
shall
not
2


employ
a
person
who
is
under
eighteen
years
of
age
or
who
has
3


been
convicted
of
a
disqualifying
felony
offense.
An
employee
4


of
a
medical
cannabidiol


cannabis
manufacturer
shall
be
subject
5


to
a
background
investigation
conducted
by
the
division
of
6


criminal
investigation
of
the
department
of
public
safety
and
a
7


national
criminal
history
background
check
pursuant
to
section
8


124E.19
.
9


8.
A
medical
cannabidiol


cannabis
manufacturer
owner
shall
10


not
have
been
convicted
of
a
disqualifying
felony
offense
and
11


shall
be
subject
to
a
background
investigation
conducted
by
12


the
division
of
criminal
investigation
of
the
department
of
13


public
safety
and
a
national
criminal
history
background
check
14


pursuant
to
section
124E.19
.
15


9.
A
medical
cannabidiol


cannabis
manufacturer
shall
not
16


operate
at
the
same
physical
location
as
a
medical
cannabidiol
17


cannabis


dispensary.
18


10.
A
medical
cannabidiol


cannabis
manufacturer
shall
not
19


operate
in
any
location,
whether
for
manufacturing,
possessing,
20


cultivating,
harvesting,
transporting,
packaging,
processing,
21


or
supplying,
within
one
thousand
feet
of
a
public
or
private
22


school
existing
before
the
date
of
the
medical
cannabidiol


23


cannabis
manufacturer’s
licensure
by
the
department.
24


11.
A
medical
cannabidiol
cannabis
manufacturer
shall
25


comply
with
reasonable
restrictions
set
by
the
department
26


relating
to
signage,
marketing,
display,
and
advertising
of
27


medical
cannabidiol
cannabis
.


28


12.
a.
A
medical
cannabidiol


cannabis
manufacturer
shall


29


provide
a
reliable
and
ongoing
supply
of
medical
cannabidiol


30


cannabis
to
medical
cannabidiol
cannabis
dispensaries
pursuant
31


to
this
chapter
.
32


b.
All
manufacturing,
cultivating,
harvesting,
packaging,
33


and
processing
of
medical
cannabidiol


cannabis
shall
take
place
34


in
an
enclosed,
locked
facility
at
a
physical
address
provided
35


-11-


LSB
5589YC
(6)
88


ss/rh
11/
25





























H.F.
_____


to
the
department
during
the
licensure
process.
1


c.
A
medical
cannabidiol


cannabis
manufacturer
shall
not
2


manufacture
edible
medical
cannabidiol
cannabis
products.
3


Sec.
35.
Section
124E.8,
Code
2020,
is
amended
to
read
as
4


follows:
5


124E.8
Medical
cannabidiol
cannabis
dispensary
licensure.
6


1.
a.
The
department
shall
issue
a
request
for
proposals
7


to
select
and
license
by
April
1,
2018,
up
to
five
medical
8


cannabidiol


cannabis
dispensaries
to
dispense
medical
9


cannabidiol
cannabis
within
this
state
consistent
with
the
10


provisions
of
this
chapter
.
The
department
shall
license
new
11


medical
cannabidiol


cannabis
dispensaries
or
relicense
the
12


existing
medical
cannabidiol
cannabis
dispensaries
by
December
13


1
of
each
year.
14


b.
Information
submitted
during
the
application
process
15


shall
be
confidential
until
a
medical
cannabidiol


cannabis
16


dispensary
is
licensed
by
the
department
unless
otherwise
17


protected
from
disclosure
under
state
or
federal
law.
18


2.
As
a
condition
for
licensure,
a
medical
cannabidiol


19


cannabis
dispensary
must
agree
to
begin
supplying
medical
20


cannabidiol


cannabis
to
patients
by
December
1,
2018.
21


3.
The
department
shall
consider
the
following
factors
in
22


determining
whether
to
select
and
license
a
medical
cannabidiol


23


cannabis
dispensary:
24


a.
The
technical
expertise
of
the
medical
cannabidiol
25


cannabis
dispensary
regarding
medical
cannabidiol
cannabis
.
26


b.
The
qualifications
of
the
medical
cannabidiol
cannabis
27


dispensary’s
employees.
28


c.
The
long-term
financial
stability
of
the
medical
29


cannabidiol


cannabis
dispensary.
30


d.
The
ability
to
provide
appropriate
security
measures
on
31


the
premises
of
the
medical
cannabidiol


cannabis
dispensary.
32


e.
The
medical
cannabidiol


cannabis
dispensary’s
projection
33


and
ongoing
assessment
of
fees
for
the
purchase
of
medical
34


cannabidiol


cannabis
on
patients
with
debilitating
medical
35


-12-


LSB
5589YC
(6)
88


ss/rh
12/
25







































H.F.
_____


conditions.
1


4.
Each
entity
submitting
an
application
for
licensure
2


as
a
medical
cannabidiol


cannabis
dispensary
shall
pay
a
3


nonrefundable
application
fee
of
five
thousand
dollars
to
the
4


department.
5


Sec.
36.
Section
124E.9,
Code
2020,
is
amended
to
read
as
6


follows:
7


124E.9
Medical
cannabidiol
cannabis
dispensaries.
8


1.
a.
The
medical
cannabidiol


cannabis
dispensaries
shall
9


be
located
based
on
geographical
need
throughout
the
state
to
10


improve
patient
access.
11


b.
A
medical
cannabidiol


cannabis
dispensary
may
dispense
12


medical
cannabidiol
cannabis
pursuant
to
the
provisions
of
this
13


chapter
but
shall
not
dispense
any
medical
cannabidiol


cannabis
14


in
a
form
or
quantity
other
than
the
form
or
quantity
allowed
15


by
the
department
pursuant
to
rule.
16


2.
The
operating
documents
of
a
medical
cannabidiol
17


cannabis


dispensary
shall
include
all
of
the
following:
18


a.
Procedures
for
the
oversight
of
the
medical
cannabidiol


19


cannabis
dispensary
and
procedures
to
ensure
accurate
20


recordkeeping.
21


b.
Procedures
for
the
implementation
of
appropriate
security
22


measures
to
deter
and
prevent
the
theft
of
medical
cannabidiol


23


cannabis
and
unauthorized
entrance
into
areas
containing
24


medical
cannabidiol
cannabis
.
25


3.
A
medical
cannabidiol
cannabis
dispensary
shall
26


implement
security
requirements,
including
requirements
for
27


protection
by
a
fully
operational
security
alarm
system,
28


facility
access
controls,
perimeter
intrusion
detection
29


systems,
and
a
personnel
identification
system.
30


4.
A
medical
cannabidiol


cannabis
dispensary
shall
not
31


share
office
space
with,
refer
patients
to,
or
have
any
32


financial
relationship
with
a
health
care
practitioner.
33


5.
A
medical
cannabidiol


cannabis
dispensary
shall
not
34


permit
any
person
to
consume
medical
cannabidiol
cannabis
on
35


-13-


LSB
5589YC
(6)
88


ss/rh
13/
25































H.F.
_____


the
property
of
the
medical
cannabidiol
cannabis
dispensary.
1


6.
A
medical
cannabidiol


cannabis
dispensary
is
subject
to
2


reasonable
inspection
by
the
department.
3


7.
A
medical
cannabidiol
cannabis
dispensary
shall
not
4


employ
a
person
who
is
under
eighteen
years
of
age
or
who
has
5


been
convicted
of
a
disqualifying
felony
offense.
An
employee
6


of
a
medical
cannabidiol
cannabis
dispensary
shall
be
subject
7


to
a
background
investigation
conducted
by
the
division
of
8


criminal
investigation
of
the
department
of
public
safety
and
a
9


national
criminal
history
background
check
pursuant
to
section
10


124E.19
.
11


8.
A
medical
cannabidiol


cannabis
dispensary
owner
shall
12


not
have
been
convicted
of
a
disqualifying
felony
offense
and
13


shall
be
subject
to
a
background
investigation
conducted
by
14


the
division
of
criminal
investigation
of
the
department
of
15


public
safety
and
a
national
criminal
history
background
check
16


pursuant
to
section
124E.19
.
17


9.
A
medical
cannabidiol


cannabis
dispensary
shall
not
18


operate
at
the
same
physical
location
as
a
medical
cannabidiol


19


cannabis
manufacturer.
20


10.
A
medical
cannabidiol


cannabis
dispensary
shall
not
21


operate
in
any
location
within
one
thousand
feet
of
a
public
22


or
private
school
existing
before
the
date
of
the
medical
23


cannabidiol


cannabis
dispensary’s
licensure
by
the
department.
24


11.
A
medical
cannabidiol
cannabis
dispensary
shall
comply
25


with
reasonable
restrictions
set
by
the
department
relating
26


to
signage,
marketing,
display,
and
advertising
of
medical
27


cannabidiol
cannabis
.


28


12.
Prior
to
dispensing
of
any
medical
cannabidiol


29


cannabis


,
a
medical
cannabidiol
cannabis
dispensary
shall
do
30


all
of
the
following:
31


a.
Verify
that
the
medical
cannabidiol


cannabis
dispensary
32


has
received
a
valid
medical
cannabidiol
cannabis
registration
33


card
from
a
patient
or
a
patient’s
primary
caregiver,
if
34


applicable.
35


-14-


LSB
5589YC
(6)
88


ss/rh
14/
25

































H.F.
_____


b.
Assign
a
tracking
number
to
any
medical
cannabidiol
1


cannabis


dispensed
from
the
medical
cannabidiol
cannabis
2


dispensary.
3


c.
Properly
package
medical
cannabidiol
cannabis
in
4


compliance
with
federal
law
regarding
child
resistant
packaging
5


and
exemptions
for
packaging
for
elderly
patients,
and
6


label
medical
cannabidiol
cannabis
with
a
list
of
all
active
7


ingredients
and
individually
identifying
information.
8


Sec.
37.
Section
124E.10,
Code
2020,
is
amended
to
read
as
9


follows:
10


124E.10
Fees.
11


All
fees
collected
by
the
department
under
this
chapter
12


shall
be
retained
by
the
department
for
operation
of
the
13


medical
cannabidiol


cannabis
registration
card
program
and
14


the
medical
cannabidiol
cannabis
manufacturer
and
medical
15


cannabidiol
cannabis
dispensary
licensing
programs.
The
moneys
16


retained
by
the
department
shall
be
considered
repayment
17


receipts
as
defined
in
section
8.2
and
shall
be
used
for
any
of
18


the
department’s
duties
under
this
chapter
,
including
but
not
19


limited
to
the
addition
of
full-time
equivalent
positions
for
20


program
services
and
investigations.
Notwithstanding
section
21


8.33
,
moneys
retained
by
the
department
pursuant
to
this
22


section
shall
not
revert
to
the
general
fund
of
the
state
but
23


shall
remain
available
for
expenditure
only
for
the
purposes
24


specified
in
this
section
.
25


Sec.
38.
Section
124E.11,
subsection
1,
paragraph
a,
Code
26


2020,
is
amended
to
read
as
follows:


27


a.
The
department
shall
maintain
a
confidential
file
of
the
28


names
of
each
patient
to
or
for
whom
the
department
issues
a
29


medical
cannabidiol


cannabis
registration
card
and
the
name
of
30


each
primary
caregiver
to
whom
the
department
issues
a
medical
31


cannabidiol


cannabis
registration
card
under
section
124E.4
.
32


Sec.
39.
Section
124E.11,
subsection
1,
paragraph
b,
33


subparagraph
(1),
subparagraph
divisions
(b)
and
(d),
Code
34


2020,
are
amended
to
read
as
follows:
35


-15-


LSB
5589YC
(6)
88


ss/rh
15/
25





















H.F.
_____


(b)
To
authorized
employees
of
law
enforcement
agencies
1


of
a
state
or
political
subdivision
thereof,
but
only
for
the
2


purpose
of
verifying
that
a
person
is
lawfully
in
possession
3


of
a
medical
cannabidiol


cannabis
registration
card
issued
4


pursuant
to
this
chapter
.
5


(d)
To
any
other
authorized
persons
recognized
by
the
6


department
by
rule,
but
only
for
the
purpose
of
verifying
that
7


a
person
is
lawfully
in
possession
of
a
medical
cannabidiol
8


cannabis


registration
card
issued
pursuant
to
this
chapter
.
9


Sec.
40.
Section
124E.11,
subsection
2,
Code
2020,
is
10


amended
to
read
as
follows:
11


2.
The
department
shall
adopt
rules
pursuant
to
chapter
12


17A
to
administer
this
chapter
which
shall
include
but
not
be
13


limited
to
rules
to
do
all
of
the
following:
14


a.
Govern
the
manner
in
which
the
department
shall
consider
15


applications
for
new
and
renewal
medical
cannabidiol


cannabis
16


registration
cards.
17


b.
Ensure
that
the
medical
cannabidiol


cannabis
registration
18


card
program
operates
on
a
self-sustaining
basis.
19


c.
Establish
the
form
and
quantity
of
medical
cannabidiol


20


cannabis


allowed
to
be
dispensed
to
a
patient
or
primary
21


caregiver
pursuant
to
this
chapter
as
appropriate
to
serve
the
22


medical
needs
of
patients
with
debilitating
medical
conditions,
23


subject
to
recommendation
by
the
medical
cannabidiol


cannabis
24


board
and
approval
by
the
board
of
medicine.
25


d.
Establish
requirements
for
the
licensure
of
medical
26


cannabidiol
cannabis
manufacturers
and
medical
cannabidiol
27


cannabis
dispensaries
and
set
forth
procedures
for
medical
28


cannabidiol
cannabis
manufacturers
and
medical
cannabidiol
29


cannabis


dispensaries
to
obtain
licenses.
30


e.
Develop
a
dispensing
system
for
medical
cannabidiol
31


cannabis


within
this
state
that
provides
for
all
of
the
32


following:
33


(1)
Medical
cannabidiol


cannabis
dispensaries
within
this
34


state
housed
on
secured
grounds
and
operated
by
licensed
35


-16-


LSB
5589YC
(6)
88


ss/rh
16/
25



























H.F.
_____


medical
cannabidiol
cannabis
dispensaries.
1


(2)
The
dispensing
of
medical
cannabidiol


cannabis
to
2


patients
and
their
primary
caregivers
to
occur
at
locations
3


designated
by
the
department.
4


f.
Establish
and
collect
annual
fees
from
medical
5


cannabidiol
cannabis
manufacturers
and
medical
cannabidiol
6


cannabis
dispensaries
to
cover
the
costs
associated
with
7


regulating
and
inspecting
medical
cannabidiol
cannabis
8


manufacturers
and
medical
cannabidiol


cannabis
dispensaries.
9


g.
Specify
and
implement
procedures
that
address
public
10


safety
including
security
procedures
and
product
quality
11


including
measures
to
ensure
contaminant-free
cultivation
of
12


medical
cannabidiol


cannabis
,
safety,
and
labeling.
13


h.
Establish
and
implement
a
real-time,
statewide
medical
14


cannabidiol


cannabis
registry
management
sale
tracking
system
15


that
is
available
to
medical
cannabidiol
cannabis
dispensaries
16


on
a
twenty-four-hour-a-day,
seven-day-a-week
basis
for
the
17


purpose
of
verifying
that
a
person
is
lawfully
in
possession
18


of
a
medical
cannabidiol


cannabis
registration
card
issued
19


pursuant
to
this
chapter
and
for
tracking
the
date
of
the
sale
20


and
quantity
of
medical
cannabidiol


cannabis
purchased
by
a
21


patient
or
a
primary
caregiver.
22


i.
Establish
and
implement
a
medical
cannabidiol


cannabis
23


inventory
and
delivery
tracking
system
to
track
medical
24


cannabidiol
cannabis
from
production
by
a
medical
cannabidiol
25


cannabis
manufacturer
through
dispensing
at
a
medical
26


cannabidiol
cannabis
dispensary.
27


Sec.
41.
Section
124E.12,
subsections
1,
2,
3,
4,
5,
6,
8,


28


and
9,
Code
2020,
are
amended
to
read
as
follows:
29


1.
A
health
care
practitioner,
including
any
authorized
30


agent
or
employee
thereof,
shall
not
be
subject
to
31


prosecution
for
the
unlawful
certification,
possession,
or
32


administration
of
marijuana
under
the
laws
of
this
state
for
33


activities
arising
directly
out
of
or
directly
related
to
the
34


certification
or
use
of
medical
cannabidiol


cannabis
in
the
35


-17-


LSB
5589YC
(6)
88


ss/rh
17/
25



































H.F.
_____


treatment
of
a
patient
diagnosed
with
a
debilitating
medical
1


condition
as
authorized
by
this
chapter
.
2


2.
A
medical
cannabidiol


cannabis
manufacturer,
including
3


any
authorized
agent
or
employee
thereof,
shall
not
be
subject
4


to
prosecution
for
manufacturing,
possessing,
cultivating,
5


harvesting,
transporting,
packaging,
processing,
or
supplying
6


medical
cannabidiol
cannabis
pursuant
to
this
chapter
.
7


3.
A
medical
cannabidiol
cannabis
dispensary,
including
8


any
authorized
agent
or
employee
thereof,
shall
not
be
subject
9


to
prosecution
for
dispensing
medical
cannabidiol


cannabis
10


pursuant
to
this
chapter
.
11


4.
a.
In
a
prosecution
for
the
unlawful
possession
of
12


marijuana
under
the
laws
of
this
state
for
the
possession
13


of
medical
cannabidiol


cannabis
,
including
but
not
limited
14


to
chapters
124
and
453B
,
it
is
an
affirmative
and
complete
15


defense
to
the
prosecution
that
the
patient
has
been
diagnosed
16


with
a
debilitating
medical
condition,
used
or
possessed
17


medical
cannabidiol


cannabis
pursuant
to
a
certification
by
a
18


health
care
practitioner
as
authorized
under
this
chapter
,
and,
19


for
a
patient
eighteen
years
of
age
or
older,
is
in
possession
20


of
a
valid
medical
cannabidiol


cannabis
registration
card
21


issued
pursuant
to
this
chapter
.
22


b.
In
a
prosecution
for
the
unlawful
possession
of
marijuana
23


under
the
laws
of
this
state
for
the
possession
of
medical
24


cannabidiol


cannabis
,
including
but
not
limited
to
chapters
25


124
and
453B
,
it
is
an
affirmative
and
complete
defense
to
26


the
prosecution
that
the
person
possessed
medical
cannabidiol
27


cannabis
because
the
person
is
a
primary
caregiver
of
a
patient
28


who
has
been
diagnosed
with
a
debilitating
medical
condition
29


and
is
in
possession
of
a
valid
medical
cannabidiol


cannabis
30


registration
card
issued
pursuant
to
this
chapter
,
and
where
31


the
primary
caregiver’s
possession
of
the
medical
cannabidiol


32


cannabis


is
on
behalf
of
the
patient
and
for
the
patient’s
use
33


only
as
authorized
under
this
chapter
.
34


c.
If
a
patient
or
primary
caregiver
is
charged
with
35


-18-


LSB
5589YC
(6)
88


ss/rh
18/
25

























H.F.
_____


the
unlawful
possession
of
marijuana
under
the
laws
of
this
1


state
for
the
possession
of
medical
cannabidiol


cannabis
,
2


including
but
not
limited
to
chapters
124
and
453B
,
and
is
not
3


in
possession
of
the
person’s
medical
cannabidiol
cannabis
4


registration
card,
any
charge
or
charges
filed
against
the
5


person
for
the
possession
of
medical
cannabidiol
cannabis
6


shall
be
dismissed
by
the
court
if
the
person
produces
to
the
7


court
prior
to
or
at
the
person’s
trial
a
medical
cannabidiol
8


cannabis


registration
card
issued
to
that
person
and
valid
at
9


the
time
the
person
was
charged.
10


5.
An
agency
of
this
state
or
a
political
subdivision
11


thereof,
including
any
law
enforcement
agency,
shall
not
remove
12


or
initiate
proceedings
to
remove
a
patient
under
the
age
13


of
eighteen
from
the
home
of
a
parent
based
solely
upon
the
14


parent’s
or
patient’s
possession
or
use
of
medical
cannabidiol


15


cannabis
as
authorized
under
this
chapter
.
16


6.
The
department,
the
department
of
transportation,
17


and
any
health
care
practitioner,
including
any
authorized
18


agent
or
employee
thereof,
are
not
subject
to
any
civil
19


or
disciplinary
penalties
by
the
board
of
medicine
or
any
20


business,
occupational,
or
professional
licensing
board
21


or
entity,
solely
for
activities
conducted
relating
to
a
22


patient’s
possession
or
use
of
medical
cannabidiol


cannabis
as
23


authorized
under
this
chapter
.
Nothing
in
this
section
affects
24


a
professional
licensing
board
from
taking
action
in
response
25


to
violations
of
any
other
section
of
law.
26


8.
An
attorney
shall
not
be
subject
to
disciplinary
action
27


by
the
Iowa
supreme
court
or
attorney
disciplinary
board
for
28


providing
legal
assistance
to
a
patient,
primary
caregiver,
or
29


others
based
upon
a
patient’s
or
primary
caregiver’s
possession
30


or
use
of
medical
cannabidiol


cannabis
as
authorized
under
this


31


chapter
.
32


9.
Possession
of
a
medical
cannabidiol


cannabis
33


registration
card
or
an
application
for
a
medical
cannabidiol


34


cannabis
registration
card
by
a
person
entitled
to
possess
or
35


-19-


LSB
5589YC
(6)
88


ss/rh
19/
25





















H.F.
_____


apply
for
a
medical
cannabidiol
cannabis
registration
card
1


shall
not
constitute
probable
cause
or
reasonable
suspicion,
2


and
shall
not
be
used
to
support
a
search
of
the
person
or
3


property
of
the
person
possessing
or
applying
for
the
medical
4


cannabidiol
cannabis
registration
card,
or
otherwise
subject
5


the
person
or
property
of
the
person
to
inspection
by
any
6


governmental
agency.
7


Sec.
42.
Section
124E.13,
Code
2020,
is
amended
to
read
as
8


follows:
9


124E.13
Medical
cannabidiol


cannabis
source.
10


Medical
cannabidiol


cannabis
provided
exclusively
pursuant
11


to
a
written
certification
of
a
health
care
practitioner,
if
12


not
legally
available
in
this
state
or
from
any
other
bordering
13


state,
shall
be
obtained
from
an
out-of-state
source.
14


Sec.
43.
Section
124E.14,
Code
2020,
is
amended
to
read
as
15


follows:
16


124E.14
Out-of-state
medical
cannabidiol


cannabis
17


dispensaries.
18


The
department
of
public
health
shall
utilize
a
request
for
19


proposals
process
to
select
and
license
by
December
1,
2017,
up
20


to
two
out-of-state
medical
cannabidiol


cannabis
dispensaries
21


from
a
bordering
state
to
sell
and
dispense
medical
cannabidiol
22


cannabis


to
a
patient
or
primary
caregiver
in
possession
of
a
23


valid
medical
cannabidiol
cannabis
registration
card
issued
24


under
this
chapter
.
25


Sec.
44.
Section
124E.15,
Code
2020,
is
amended
to
read
as
26


follows:


27


124E.15
Iowa
patients
and
primary
caregivers
registering
in
28


the
state
of
Minnesota.


29


A
patient
or
a
primary
caregiver
with
a
valid
medical
30


cannabidiol


cannabis
registration
card
issued
pursuant
to
this
31


chapter
may
register
in
the
state
of
Minnesota
as
a
visiting
32


qualified
patient
or
primary
caregiver
and
may
register
with
33


one
or
more
medical
cannabis
manufacturers
registered
under
the
34


laws
of
Minnesota.
35


-20-


LSB
5589YC
(6)
88


ss/rh
20/
25





















H.F.
_____


Sec.
45.
Section
124E.16,
Code
2020,
is
amended
to
read
as
1


follows:
2


124E.16
Penalties.
3


1.
A
person
who
knowingly
or
intentionally
possesses
or
uses
4


medical
cannabidiol
cannabis
in
violation
of
the
requirements
5


of
this
chapter
is
subject
to
the
penalties
provided
under
6


chapters
124
and
453B
.
7


2.
A
medical
cannabidiol


cannabis
manufacturer
or
a
medical
8


cannabidiol


cannabis
dispensary
shall
be
assessed
a
civil
9


penalty
of
up
to
one
thousand
dollars
per
violation
for
any
10


violation
of
this
chapter
in
addition
to
any
other
applicable
11


penalties.
12


Sec.
46.
Section
124E.17,
Code
2020,
is
amended
to
read
as
13


follows:
14


124E.17
Use
of
medical
cannabidiol


cannabis
——
smoking
15


prohibited.
16


A
patient
shall
not
consume
medical
cannabidiol
cannabis
17


possessed
or
used
as
authorized
under
this
chapter
by
smoking
18


medical
cannabidiol


cannabis
.
19


Sec.
47.
Section
124E.18,
Code
2020,
is
amended
to
read
as
20


follows:
21


124E.18
Reciprocity.
22


A
valid
medical
cannabidiol


cannabis
registration
card,
23


or
its
equivalent,
issued
under
the
laws
of
another
state
24


that
allows
an
out-of-state
patient
to
possess
or
use
medical
25


cannabidiol
cannabis
in
the
jurisdiction
of
issuance
shall
26


have
the
same
force
and
effect
as
a
valid
medical
cannabidiol
27


cannabis
registration
card
issued
pursuant
to
this
chapter
,
28


except
that
an
out-of-state
patient
in
this
state
shall
not
29


obtain
medical
cannabidiol


cannabis
from
a
medical
cannabidiol
30


cannabis
dispensary
in
this
state.
31


Sec.
48.
Section
124E.19,
subsections
1,
2,
and
4,
Code
32


2020,
are
amended
to
read
as
follows:
33


1.
The
division
of
criminal
investigation
of
the
34


department
of
public
safety
shall
conduct
thorough
background
35


-21-


LSB
5589YC
(6)
88


ss/rh
21/
25

























H.F.
_____


investigations
for
the
purposes
of
licensing
medical
1


cannabidiol


cannabis
manufacturers
and
medical
cannabidiol
2


cannabis
dispensaries
under
this
chapter
.
The
results
of
any
3


background
investigation
conducted
pursuant
to
this
section
4


shall
be
presented
to
the
department.
5


a.
An
applicant
for
a
medical
cannabidiol
cannabis
6


manufacturer
license
or
a
medical
cannabidiol
cannabis
7


dispensary
license
and
their
owners,
investors,
and
employees
8


shall
submit
all
required
information
on
a
form
prescribed
by
9


the
department
of
public
safety.
10


b.
The
department
shall
charge
an
applicant
for
a
medical
11


cannabidiol


cannabis
manufacturer
license
or
a
medical
12


cannabidiol
cannabis
dispensary
license
a
fee
determined
by
13


the
department
of
public
safety
and
adopted
by
the
department
14


by
rule
to
defray
the
costs
associated
with
background
15


investigations
conducted
pursuant
to
the
requirements
of
this
16


section
.
The
fee
shall
be
in
addition
to
any
other
fees
17


charged
by
the
department.
The
fee
may
be
retained
by
the
18


department
of
public
safety
and
shall
be
considered
repayment
19


receipts
as
defined
in
section
8.2
.
20


2.
The
department
shall
require
an
applicant
for
a
21


medical
cannabidiol


cannabis
manufacturer
license
or
a
22


medical
cannabidiol


cannabis
dispensary
license,
their
owners
23


and
investors,
and
applicants
for
employment
at
a
medical
24


cannabidiol
cannabis
manufacturer
or
medical
cannabidiol
25


cannabis
dispensary
to
submit
fingerprints
and
other
required
26


identifying
information
to
the
department
on
a
form
prescribed
27


by
the
department
of
public
safety.
The
department
shall
28


submit
the
fingerprint
cards
and
other
identifying
information
29


to
the
division
of
criminal
investigation
of
the
department
30


of
public
safety
for
submission
to
the
federal
bureau
of
31


investigation
for
the
purpose
of
conducting
a
national
criminal
32


history
record
check.
The
department
may
require
employees
and
33


contractors
involved
in
carrying
out
a
background
investigation
34


to
submit
fingerprints
and
other
identifying
information
for
35


-22-


LSB
5589YC
(6)
88


ss/rh
22/
25























H.F.
_____


the
same
purpose.
1


4.
An
applicant
for
a
medical
cannabidiol


cannabis
2


manufacturer
license
or
a
medical
cannabidiol
cannabis
3


dispensary
license
shall
submit
information
and
fees
required
4


by
this
section
at
the
time
of
application.
5


Sec.
49.
Section
204.17,
subsection
4,
Code
2020,
is
amended
6


to
read
as
follows:
7


4.
Nothing
in
this
chapter
shall
be
construed
or
applied
8


to
authorize
a
person
to
manufacture,
recommend,
possess,
use,
9


dispense,
deliver,
transport,
or
administer
medical
cannabidiol


10


cannabis


pursuant
to
chapter
124E
.
11


Sec.
50.
Section
730.5,
subsection
11,
paragraph
f,
Code
12


2020,
is
amended
to
read
as
follows:
13


f.
Testing
or
taking
action
against
an
employee
or
14


prospective
employee
with
a
confirmed
positive
test
result
due
15


to
the
employee’s
or
prospective
employee’s
use
of
medical
16


cannabidiol


cannabis
as
authorized
under
chapter
124E
.
17


EXPLANATION
18


The
inclusion
of
this
explanation
does
not
constitute
agreement
with
19


the
explanation’s
substance
by
the
members
of
the
general
assembly.
20


This
bill
relates
to
the
medical
cannabidiol
program.
The
21


bill
is
organized
into
divisions.
22


DIVISION
I
——
MEDICAL
CANNABIDIOL
PROGRAM.
The
bill
changes
23


the
name
of
the
medical
cannabidiol
Act
to
the
medical
cannabis
24


Act.
25


The
bill
adds
physician
assistants,
advanced
registered
26


nurse
practitioners,
advanced
practice
registered
nurses,
and
27


podiatrists
to
the
list
of
health
care
practitioners
allowed
to
28


certify
a
patient
to
receive
a
medical
cannabidiol
registration
29


card.
30


The
bill
removes
the
3
percent
tetrahydrocannabinol
(THC)
31


limit
on
medical
cannabidiol.
The
bill
prohibits
a
medical
32


cannabidiol
patient
or
a
patient’s
primary
caregiver
from
33


receiving
more
than
4.5
grams
of
total
THC
in
a
90-day
period.
34


The
bill
allows
medical
cannabidiol
dispensaries
to
access
the
35


-23-


LSB
5589YC
(6)
88


ss/rh
23/
25











H.F.
_____


files
of
the
department
of
public
health
to
determine
whether
1


a
patient
has
received
more
than
4.5
grams
of
total
THC
in
a
2


90-day
period.
The
bill
defines
“total
THC”
as
the
amount
of
3


THC
plus
the
amount
of
tetrahydrocannabinolic
acid.
4


The
bill
removes
the
department
of
transportation
from
the
5


process
of
issuing
medical
cannabidiol
registration
cards
and
6


makes
conforming
Code
changes.
The
bill
directs
the
department
7


of
public
health
to
issue
medical
cannabidiol
registration
8


cards.
9


The
bill
removes
the
prohibitions
on
patients
and
primary
10


caregivers
with
certain
disqualifying
felony
offenses
from
11


receiving
a
medical
cannabidiol
registration
card.
12


The
bill
removes
the
limit
on
the
number
of
meetings
per
year
13


of
the
medical
cannabidiol
board.
Current
law
sets
the
maximum
14


number
of
meetings
to
four
per
year.
15


The
bill
requires
medical
cannabidiol
dispensaries
to
employ
16


a
pharmacist
or
pharmacy
technician
for
the
purpose
of
making
17


medical
cannabidiol
dosing
recommendations.
18


The
bill
allows
health
care
practitioners
to
access
the
19


patient
registry
maintained
by
the
department
of
public
health
20


to
determine
whether
a
patient
seeking
a
written
certification
21


for
a
medical
cannabidiol
registration
card
has
already
22


received
a
written
certification
from
another
health
care
23


practitioner.
24


The
bill
requires
the
department
of
public
health
to
25


conduct
an
observational
effectiveness
study,
in
cooperation
26


with
patients
and
health
care
practitioners,
on
the
efficacy
27


of
medical
cannabis
products.
The
bill
also
requires
the
28


department
to
seek
guarantees
from
federal
agencies
that
29


provide
funding
to
educational
and
long-term
care
facilities
30


that
facilities
with
policies
allowing
patients
to
possess
31


medical
cannabis
on
the
property
of
the
facility
or
allowing
32


facility
staff
to
administer
medical
cannabis
to
a
patient
33


will
not
lose
eligibility
for
any
federal
funding
due
to
such
34


policies.
35


-24-


LSB
5589YC
(6)
88


ss/rh
24/
25



H.F.
_____


The
bill
provides
that
a
medical
cannabidiol
registration
1


card
issued
prior
to
July
1,
2020,
by
the
department
of
2


transportation
shall
remain
valid
until
the
card’s
expiration
3


date.
4


DIVISION
II
——
CONFORMING
CODE
CHANGES.
This
division
5


changes
references
to
“medical
cannabidiol”
to
“medical
6


cannabis”
throughout
the
Code.
7


-25-


LSB
5589YC
(6)
88


ss/rh
25/
25

